Live coverage: 2-year-old Matthew Ouimet undergoes transplant surgerySan Jose Mercury NewsMatthew Ouimet, 2, of Antioch, is underdoing a 9-hour liver and kidney transplant at 10 a.m Tuesday a UCSF Medical Center Follow reports from reporter Gary Peters…
ASCO: Afinitor Quells Herceptin Resistance – MedPage Today
|
ASCO: Afinitor Quells Herceptin Resistance
MedPage Today In the BOLERO-3 trial, everolimus (Afinitor) significantly extended the time before relapse in patients resistant to trastuzumab (Herceptin), reported Ruth O’Regan, MD, of Emory University in Atlanta. There were also fewer deaths among women treated … |
Relief for Itchy Pets – Huffington Post
Relief for Itchy PetsHuffington PostIf your pet is severely itchy and uncomfortable, in some instances, I will prescribe immuno-modulating drugs, like oral steroids or modified cyclosporine. A steroid, like prednisolone, can be given orally once or twi…
Receptive to Receptos – Barron's
Receptive to ReceptosBarron’sFaheem Hasnain, chief executive, previously developed daclizumab for RMS as CEO of Facet, which was acquired by Abbott Laboratories (ABT) in April 2010. Not only does he have a great track record developing multiple scleros…
Knome Teams with Omixon to Provide Whole Genome, Exome HLA Typing – GenomeWeb
|
Knome Teams with Omixon to Provide Whole Genome, Exome HLA Typing
GenomeWeb NEW YORK (GenomeWeb News) – Knome has announced that its services division will now offer Omixon’s targeted human leukocyte antigen typing capabilities as part of its whole genome and exome interpretation pipelines. Omixon CEO Attila Berces said … |
URGENT ACTION : STOP VIOLENCE AGAINST PEACUFUL PROTESTORS IN … – FIDH
URGENT ACTION : STOP VIOLENCE AGAINST PEACUFUL PROTESTORS IN …FIDHWe are deeply concern that there are strong and just claim about brain death of a young person in Ankara because of violence attacks. Moreover, as result of chemical gas attacks and ph…
Το Everolimus καθυστερεί σημαντικά την ανάπτυξη του όγκου στον καρκίνο μαστού – iatronet.gr
iatronet.gr |
Το Everolimus καθυστερεί σημαντικά την ανάπτυξη του όγκου στον καρκίνο μαστού
iatronet.gr Στις 2 Ιουνίου 2013, τα αποτελέσματα της κλινικής μελέτης Φάσης ΙΙΙ στον καρκίνο μαστού προχωρημένου σταδίου, BOLERO-3, της εταιρείας Novartis παρουσιάστηκαν στο 49ο Ετήσιο Συνέδριο της Αμερικανικής Εταιρείας Κλινικής Ογκολογίας (ASCO). |
Delhi HC seeks AIIMS reponse on kidney patient's plea for transplant – Zee News
|
Delhi HC seeks AIIMS reponse on kidney patient’s plea for transplant
Zee News Gupta’s counsel Atul Wadhera said after the patient’s family members had expressed their inability to donate the organ to him, the high court on May 21, 2010 had directed AIIMS to arrange a donor. Pursuant the court order, Gupta had registered himself … |
Bid to change organ donation laws – Belfast Telegraph
Belfast Telegraph |
Bid to change organ donation laws
Belfast Telegraph Former gaelic football all-Ireland winner turned organ donor champion Joe Brolly said a proposed change to the law at Stormont had given patients on “death row” hope that there was now light at the end of the tunnel. Mr Brolly was attending the launch … GAA star Brolly continues bid to change organ donor lawBelfast Newsletter |
France suffers from organ failure – The Guardian
The Guardian |
France suffers from organ failure
The Guardian On 12 December 2012, after 10 months’ restoration work and silence, the great organ of Notre Dame de Paris – the largest in France, with five keyboards, 109 stops and nearly 8,000 pipes – opened the festivities for the cathedral’s 850th anniversary … |